Basics Reviva Pharmaceuticals Holdings, Inc. IPO Date: October 15, 2018 Sector: Healthcare Industry: Biotech Market Cap: $41.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 4.66% Avg Daily Range (30 D): $0.05 | 4.95% Avg Daily Range (90 D): $0.05 | 5.11% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 234 Avg Trade Size (Sh.) (30 D): 393 Avg Trade Size (Sh.) (90 D): 318 Institutional Trades Total Inst.Trades: 13 Avg Inst. Trade: $.82M Avg Inst. Trade (30 D): $.71M Avg Inst. Trade (90 D): $.71M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.81M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 141.35K     News May 1, 2025 @ 5:00 PM Schizophrenia Market to Witness Significant Growth... Source: Delveinsight Jan 30, 2025 @ 1:00 PM Reviva to Participate in the 2025 BIO CEO & Invest... Source: N/A Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Dec 16, 2024 @ 10:18 PM Reviva Announces Proposed Public Offering Source: N/A Oct 9, 2024 @ 5:00 PM Schizophrenia Clinical Trial Pipeline Insights Fea... Source: Delveinsight Financials   TTM Q4 2024 FY 2024 Basic EPS $-.13 $-.15 $-.9 Diluted EPS Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -6.43M $ -6.26M $ -29.92M Operating Income / Loss $ -6.54M $ -6.28M $ -30.8M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio